April 20, 2021
A Corporate M&A Series: Your Next Deal Will Be Different - Part 2
As the COVID-19 pandemic spread across the globe in early 2020, its impact on M&A volume was immediate. M&A activity rebounded with announced volumes for the 4th quarter of 2020 exceeding 2019 levels. Still, the pandemic recalibrated the ways in which buyers and sellers analyze and value targets.
In the second installment of A&M’s Your Next Deal Will Be Different series, we examine common COVID-19 adjustments that buyers and sellers are making to EBITDA, trends in valuation and forecasts, and trends in contingent consideration provisions.
![]() |
![]() |
Read the Other Reports in this Series: